National Institute of Mental Health; Notice of Closed Meetings, 52551 [06-7434]
Download as PDF
Federal Register / Vol. 71, No. 172 / Wednesday, September 6, 2006 / Notices
can help diagnose or follow up on the
progress of a variety of diseases,
including Huntington’s Disease,
olivopontocerebellar atrophy, epilepsy,
schizophrenia, as well as hepatitis,
cirrhosis, cholangitis, Gilbert’s diseases,
muscular dystrophy, leukemia, kidney
inflammation, cardiac infarction, or the
presence of a tumor. Thus, tissue AST
activity may become a novel marker of
brain disorders which has been
inaccessible using current clinical
technologies.
Applications and Market: Diagnosis
and monitoring disease status in a
variety of diseases, including
Huntington’s Disease,
olivopontocerebellar atrophy, epilepsy,
schizophrenia, as well as hepatitis,
cirrhosis, cholangitis, Gilbert’s diseases,
muscular dystrophy, leukemia, kidney
inflammation, cardiac infarction, or the
presence of a tumor. The diagnostic
market is a multi-billion dollar market,
with a need for more efficient noninvasive techniques, markers and new
methods of diagnosis.
Patent Status: U.S. Patent Application
No. 11/356,214 filed 21 Feb 2006 (HHS
Reference No. E–231–2005/0–US–02).
Inventors: Dr. Jun Shen (NIMH).
Publication: J Shen. In vivo carbon-13
magnetization transfer effect: detection
of aspartate aminotransferase reaction.
Magn Reson Med. 2005 Dec; 54(6):1321–
1326.
Licensing Status: Available for
exclusive or non-exclusive licensing.
Licensing Contact: Chekesha
Clingman, Ph.D.; 301/435–5018;
clingman@mail.nih.gov.
Dated: August 29, 2006.
Steven M. Ferguson,
Director, Division of Technology Development
and Transfer, Office of Technology Transfer,
National Institutes of Health.
[FR Doc. 06–7439 Filed 9–5–06; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
rwilkins on PROD1PC63 with NOTICES
National Center for Complementary &
Alternative Medicine; Amended Notice
of Meeting
Notice is hereby given of a change in
the meeting of the National Advisory
Council for Complementary and
Alternative Medicine, September 8,
2006, 9 a.m. to September 8, 2006, 4
p.m., National Institutes of Health,
Neuroscience Building, 6001 Executive
Boulevard, Rooms C & D, Rockville, MD
20852, which was published in the
VerDate Aug<31>2005
18:44 Sep 05, 2006
Jkt 208001
Federal Register on July 28, 2006, 71 FR
42860.
This meeting is being amended due to
the start time change for the Open
session from 2 p.m. to 1:30 p.m. The
meeting is partially Closed to the public.
Dated: August 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–7436 Filed 9–5–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
NIMH Eating Disorders Grant Application
Review.
Date: September 29, 2006.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Bettina D. Osborn, Ph.D.,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6154, MSC 9609,
Rockville, MD 20852–9609, 301–443–1178,
acunab@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Mental Health Centers for Intervention
Development and Applied Research (CIDAR).
Date: October 12–13, 2006.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Park Hotel, 8400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: A. Roger Little, Ph.D.,
Scientific Review Administrator, Division of
Extramural Activities, National Institute of
Frm 00029
Fmt 4703
Sfmt 4703
Mental Health, National Institutes of Health,
6001 Executive Blvd., Room 6157, MSC 9609,
Rockville, MD 20852–9609, 301–402–5844,
alittle@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
Dated: August 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–7434 Filed 9–5–06; 8:45 am]
BILLING CODE 4140–01–M
National Institutes of Health
PO 00000
52551
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Diabetes and
Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of changes in
the meeting of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council, September 20, 2006, 8:30 a.m.
to September 21, 2006, 12 p.m.,
National Institutes of Health, Building
31, 31 Center Drive, Bethesda, MD
20892, which was published in the
Federal Register on August 18, 2006, 71
FR 47820–47821.
Name of Committee: National Diabetes and
Digestive and Kidney Diseases Advisory
Council.
Date: September 20–21, 2006.
Open: September 20, 2006, 8:30 a.m. to 12
p.m.
Agenda: To present the Director’s Report
and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Open: September 20, 2006, 4 p.m. to 5 p.m.
Agenda: Report from the NIH Director.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: September 21, 2006, 9:45 a.m. to
10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Open: September 21, 2006, 10:15 a.m. to 12
p.m.
Agenda: Continuation of the Director’s
Report and other scientific presentations.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Brent B. Stanfield, Ph.D.,
Director, Division of Extramural Activities,
National Institutes of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Blvd.,
E:\FR\FM\06SEN1.SGM
06SEN1
Agencies
[Federal Register Volume 71, Number 172 (Wednesday, September 6, 2006)]
[Notices]
[Page 52551]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-7434]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; NIMH Eating Disorders Grant Application Review.
Date: September 29, 2006.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Telephone Conference
Call).
Contact Person: Bettina D. Osborn, Ph.D., Scientific Review
Administrator, Division of Extramural Activities, National Institute
of Mental Health, National Institutes of Health, 6001 Executive
Blvd., Room 6154, MSC 9609, Rockville, MD 20852-9609, 301-443-1178,
acunab@mail.nih.gov.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Mental Health Centers for Intervention Development
and Applied Research (CIDAR).
Date: October 12-13, 2006.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Park Hotel, 8400 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: A. Roger Little, Ph.D., Scientific Review
Administrator, Division of Extramural Activities, National Institute
of Mental Health, National Institutes of Health, 6001 Executive
Blvd., Room 6157, MSC 9609, Rockville, MD 20852-9609, 301-402-5844,
alittle@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.242,
Mental Health Research Grants; 93.281, Scientist Development Award,
Scientist Development Award for Clinicians, and Research Scientist
Award; 93.282, Mental Health National Research Service Awards for
Research Training, National Institutes of Health, HHS)
Dated: August 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-7434 Filed 9-5-06; 8:45 am]
BILLING CODE 4140-01-M